Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/28/2005EP1207885B1 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1104294B1 Compositions and methods of treating abnormal cell proliferation
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005EP1085804A4 Method and composition for the treatment of epidermal irritations and infections
09/28/2005EP1082292B1 Control of pain with endogenous cannabinoids
09/28/2005EP1051655B1 Methods and apparatus for accelerated orthokeratology
09/28/2005EP1008344B1 New dicaffeoylquinic acid derivatives and their use for treating hepatitis b
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005EP0944639A4 Synthetic glycoamines, methods for their use that affect cell
09/28/2005EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
09/28/2005CN1675376A Inhibitors of inflammatory gene activity and cholesterol biosynthesis
09/28/2005CN1675359A Novel forms of interfering rna molecules
09/28/2005CN1675344A Oil or fat composition
09/28/2005CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
09/28/2005CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
09/28/2005CN1675248A Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof
09/28/2005CN1675235A Partial and full agonists of AL adenosine receptors
09/28/2005CN1675233A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
09/28/2005CN1675232A Derivatives of monosaccharides for drug discovery
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675225A Macrocyclic pyrimidines, their production and use as pharmaceutical agents
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675223A C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675222A C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675220A Epothilone derivatives
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675215A Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
09/28/2005CN1675214A Pyrimido compounds having antiproliferative activity
09/28/2005CN1675211A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675204A 2-heteroaryl carboxamides
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675200A Process for preparing 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675195A Inhibitors of tyrosine kinases
09/28/2005CN1675194A Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
09/28/2005CN1675193A Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide
09/28/2005CN1675192A Novel compunds, pharmaceutical compositions containing same, and methods of use for same
09/28/2005CN1675189A Novel use of benzothiazole derivatives
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675183A Acutumine and acutumine compound synthesis and use
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1675177A Modafinil polymorphic forms
09/28/2005CN1675173A Muscarinic agonists
09/28/2005CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675169A Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675165A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
09/28/2005CN1675159A Method and device for producing formic acid formates and use of said formates
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674959A Use of a PPAR-alpha agonist to treat weight gain associated with a PPAR-gamma agonist treatment
09/28/2005CN1674943A Radioactively labelled amino acid analogues, their preparation and use
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674941A Solid nano-medicine and preparing method thereof
09/28/2005CN1674940A Topical anhydrous and ethanol-free ascomycin compositions
09/28/2005CN1674939A Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD
09/28/2005CN1674938A Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer
09/28/2005CN1674937A Remedy or preventive for kidney disease and method of diagnosing kidney disease
09/28/2005CN1674936A Treatment of MS with goat serum
09/28/2005CN1674935A Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition
09/28/2005CN1674925A Anti-microbial agent and anti-microbial composition
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674920A Process for preparing a sterile high molecular weight hyaluronic acid formulation
09/28/2005CN1674919A Use of cgrp antagonist compounds for treatment of psoriasis
09/28/2005CN1674917A Treatment of human multiple myeloma by curcumin
09/28/2005CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
09/28/2005CN1674915A A method of treating human skin and a skin care composition for use in such a method
09/28/2005CN1674914A Female hormone-containing patch
09/28/2005CN1674913A Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
09/28/2005CN1674912A Methods of treatment of male erectile dysfunction
09/28/2005CN1674911A Medicament and method for reducing alcohol and/or tobacco consumption
09/28/2005CN1674910A Combination of azelastine and steroids
09/28/2005CN1674909A Use of carboxamides for the treatment of tinnitus
09/28/2005CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674905A Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
09/28/2005CN1674904A Process for hydroxyazapirones
09/28/2005CN1674903A Composition for transnasal absorption
09/28/2005CN1674902A Novel crystalline forms of gatifloxacin
09/28/2005CN1674901A Novel salt and polymorphs of desloratadine hemifumarate
09/28/2005CN1674900A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
09/28/2005CN1674899A Use of IkappaB-kinase inhibitors in pain therapy
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases
1 ... 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 4539 4540 4541 4542 4543 4544 4545 4546 4547 ... 7860